OPR - Delayed Quote • USD FATE Aug 2024 5.000 put (FATE240816P00005000) Follow 1.1500 0.0000 (0.00%) As of April 24 at 10:41 AM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for FATE240816P00005000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: FATE Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report? Why Is Myriad (MYGN) Down 1% Since Last Earnings Report? Fate Therapeutics (FATE) Down 8% Since Last Earnings Report: Can It Rebound? Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2023 Earnings Call Transcript Fate Therapeutics to Present at Upcoming March Investor Conferences Fate Therapeutics, Inc. (NASDAQ:FATE) Just Reported And Analysts Have Been Lifting Their Price Targets Fate Therapeutics Full Year 2023 Earnings: EPS Beats Expectations
